46
46
Jan 10, 2022
01/22
by
BLOOMBERG
tv
eye 46
favorite 0
quote 0
we will discuss that with the ceo of novavax. stan erck joins us next.is bloomberg. ♪ >> iran's foreign ministry says it wants a copper has a nuclear deal with world powers that removes sanctions, including on oil x arts and will not settle for an interim agreement. the comments come as efforts continue to revive the 2015 accord that limited iran's atomic activities in return for u.s. sanctions relief. the u.k. education minister says the country is on a path toward transitioning from pandemic to endemic. the minister also suggested it would help to cut isolation periods to five days to ease workforce shortages. public schools in chicago are closed again for the fourth straight academic day. authorities have not reached a deal with the teachers union over more measures to prevent coronavirus. teachers voted to shift back to remote learning. the district because that an illegal strike. new york mayor eric adams has revised the death toll in that dudley fire, saying 17 people were killed, two fewer than thought. a malfunctioning space heater is to blame fo
we will discuss that with the ceo of novavax. stan erck joins us next.is bloomberg. ♪ >> iran's foreign ministry says it wants a copper has a nuclear deal with world powers that removes sanctions, including on oil x arts and will not settle for an interim agreement. the comments come as efforts continue to revive the 2015 accord that limited iran's atomic activities in return for u.s. sanctions relief. the u.k. education minister says the country is on a path toward transitioning from...
116
116
Jan 20, 2022
01/22
by
CNBC
tv
eye 116
favorite 0
quote 0
and novavax down only 56%. pfizer we stuck in there of course because it is a big vaccine maker.t is not doing the same thing and of course has a covid anti-viral as well as the rest of the giant pharmaceuticals business but lot of this is about the uncertainty of what the covid vaccine business looks like over time you can see that while it is up to 20 billion this year for 2022 that really starts to go down significantly after that the thing that's different about moderna, though, an analyst pointed out, it has other things going none the whole mrna platform it is still in the covid vaccine space. in march we are expecting data for kids ages 2 to 5 for the covid vaccine. late they are year we will hear more about plans for updating the vaccines for new variants. comb kron, potentially incorporating other variants as well into the covid vaccine. beyond that, vaccines for flu, rsv, epstein barr and other viruses moderna is working on as well there are other things going on here, but hard to escape the covid trade. >> meg laid out the case here. the critical i think so this, what'
and novavax down only 56%. pfizer we stuck in there of course because it is a big vaccine maker.t is not doing the same thing and of course has a covid anti-viral as well as the rest of the giant pharmaceuticals business but lot of this is about the uncertainty of what the covid vaccine business looks like over time you can see that while it is up to 20 billion this year for 2022 that really starts to go down significantly after that the thing that's different about moderna, though, an analyst...
141
141
Jan 26, 2022
01/22
by
CNBC
tv
eye 141
favorite 0
quote 0
as for novavax, single was right. i say i like nova grates, not novavax. no thank you i haven't been able to get the fda approval that they have been telling you they would get for the covid vaccine. and then finally there is sam adams and truly hard seltzer the business has gotten way to competitive. they're in the penalty box well so i got upstart, okay. better than a sharp stick in the eye. how about the remaining 89 companies that are smaller than $5 billion i'm willing to stick my neck out. resolve group is a digital power retailers unfairly punished, last quarter was excellent you have bed bath&beyond and that is worth more than it is selling for. and nordstrom family owned and where kohl's could have two takeover bids, i can't resist the stock and i think the buy buy baby unit is worth the price of the entire company. call me good, good, good okay now i'm also in touch by course air gaming a lot of great things about gaming and their a partial competitor this one got bit up by the meme stock crew and after that course air pump and dump was over, it
as for novavax, single was right. i say i like nova grates, not novavax. no thank you i haven't been able to get the fda approval that they have been telling you they would get for the covid vaccine. and then finally there is sam adams and truly hard seltzer the business has gotten way to competitive. they're in the penalty box well so i got upstart, okay. better than a sharp stick in the eye. how about the remaining 89 companies that are smaller than $5 billion i'm willing to stick my neck...
55
55
Jan 10, 2022
01/22
by
CNBC
tv
eye 55
favorite 0
quote 0
we'll talk to the ceo ceo of nov novavax ahead of a busy week. >> we are 30 minutes into the tradingvers waerpg watching, lululemon expecting q4 earnings coming in at the low end of its projected ranging, due to staffing shortages and shortened core store hours as covid cases surge in the u.s plus deutsche bank upgrading viacom cbs to buy from hold based on upbeat prospects for its streaming business, now down a little over 1% finally we will end with the deal of the morning, which is take two interactive buying zynga for $12.7 billion depending on how you look at it. we have a lot more on that move, that deal, later this hour you can see, though, shares of take two are down 12%. zynga soaring more than 46%. we're going to turn to the broader markets. stocks moving lower to start the second full week of 2022 joining us schwab cio omar and morgan stanley analyst brian. good morning to you both omar, i'll start with you. the fact that we have another day with a lot of red arrows, we've seen this big rotation from growth into cyclicals as interest rates have moved higher and moved highe
we'll talk to the ceo ceo of nov novavax ahead of a busy week. >> we are 30 minutes into the tradingvers waerpg watching, lululemon expecting q4 earnings coming in at the low end of its projected ranging, due to staffing shortages and shortened core store hours as covid cases surge in the u.s plus deutsche bank upgrading viacom cbs to buy from hold based on upbeat prospects for its streaming business, now down a little over 1% finally we will end with the deal of the morning, which is...
110
110
Jan 31, 2022
01/22
by
KGO
tv
eye 110
favorite 0
quote 0
kristen: also tonight, novavax, that vaccine, they have applied to the fda for authorization. that is a u.s. biotech company. the vaccine has been used in a few other countries, mainly in asia. how is this one different? is it needed here? dr. fukuda: i'm sorry, i don't know about that particular company. i know the details of the pfizer, in particular, because i knew that was coming. i'm sorry, i cannot answer that. kristen: that's ok. we probably won't be needing it, even in this country. but they did apply for authorization. i want to talk about governors across the country seem to be saying we need to learn to live with this, it is time to manage this like an end i make rather than a pandemic. do you agree with that and what does that mean to you if we were to start thinking of it as an endemic now? dr. fukuda: i think two years is a long time for us to be in this pandemic. understandably, we want a vision for the future. we are in a different place than when this pandemic started. we have vaccinations and by the way, statistics show in california, five to 11 who have gott
kristen: also tonight, novavax, that vaccine, they have applied to the fda for authorization. that is a u.s. biotech company. the vaccine has been used in a few other countries, mainly in asia. how is this one different? is it needed here? dr. fukuda: i'm sorry, i don't know about that particular company. i know the details of the pfizer, in particular, because i knew that was coming. i'm sorry, i cannot answer that. kristen: that's ok. we probably won't be needing it, even in this country. but...
79
79
Jan 10, 2022
01/22
by
BLOOMBERG
tv
eye 79
favorite 0
quote 0
novavax says it has shipped its first dose of its covid vaccine to europe. the novavax jab is already used in several countries in asia and the country expects feedback from u.s. regulators sometimes -- sometime next month. the shock can protect from covid and the flu in one shot -- vax can protect from covid and the flu in one shot. both the u.s. and russia signal interest in further negotiations. >> on some of the issues, there might be basis for future exchanges. hopefully also some progress. >> china's governor says the country will speed up investments in key projects and boost domestic consumption. a state council meeting urged faster, limitation of more than 100 projects. it says proceeds could lower government debt sales could be used to fund them. global news, 24 hours a day on air and on quicktake, powered by more than 2700 journalists and analysts in more than 120 countries. i am vonnie quinn, this is bloomberg. >> coming up next, more on the policy outlook as jerome powell heads to capitol hill. the u.s. 10 year yield could hit 3%. nasa looked at
novavax says it has shipped its first dose of its covid vaccine to europe. the novavax jab is already used in several countries in asia and the country expects feedback from u.s. regulators sometimes -- sometime next month. the shock can protect from covid and the flu in one shot -- vax can protect from covid and the flu in one shot. both the u.s. and russia signal interest in further negotiations. >> on some of the issues, there might be basis for future exchanges. hopefully also some...
24
24
Jan 16, 2022
01/22
by
BBCNEWS
tv
eye 24
favorite 0
quote 0
example don't have the infrastructure to distribute it and it requires something more flexible and novavaxuch delayed that they had hoped would be a solution and would be a much simpler response. it's still having problems, it's not been produced yet in the us, so there have been technical and logistical problems but they are also financial problems for this grand pledge of a billion vaccines to the world is not getting enough funding and has said if we don't get more funding we cannot keep this going because it's not simply about sending vaccines to countries in the developing world and saying go for it, there has to be a huge amount of support and education and training involved in order for these things to be successful. the health threat to all of us and to everyone on the planet is even if we are triple and quadruple vaccinated a year or two from now, if a huge part of the planet is not an coronavirus keeps mutating and if we go through the greek alphabet and run out of letters for these mutations and we are all going to be vulnerable to something potentially lethal if we don't get th
example don't have the infrastructure to distribute it and it requires something more flexible and novavaxuch delayed that they had hoped would be a solution and would be a much simpler response. it's still having problems, it's not been produced yet in the us, so there have been technical and logistical problems but they are also financial problems for this grand pledge of a billion vaccines to the world is not getting enough funding and has said if we don't get more funding we cannot keep...
30
30
Jan 4, 2022
01/22
by
BLOOMBERG
tv
eye 30
favorite 0
quote 0
biontech and novavax also low. these stocks were up last year and a little bit of a reversal.e wondering is there light at the end of the tunnel, how effective are the vaccines given the breakthrough cases. it is unclear what is behind this. despite the pfizer contract for 10 million doses, you would think the stock would be up. guy: it is off its lows. there is some positive news. abigail, thank you bring much. coming up, let's talk about what the next when he for hours will look like. in a few minutes boris johnson will deliver a virtual news conference from 10 downing street updated the u.k. population as covid cases continued to search. -- continue to surge. biden and harris having a covid meeting this afternoon as well. it is moving at a pace and the regulations are changing quickly as everyone tries to figure out how we adapt. alix: tomorrow we get u.s. mortgage applications. adp numbers and the fed minutes. that will be front and center as we read through the tea leaves. that wraps it up for us. "balance of power" is up next. guy and i had to the cable on dab digital ra
biontech and novavax also low. these stocks were up last year and a little bit of a reversal.e wondering is there light at the end of the tunnel, how effective are the vaccines given the breakthrough cases. it is unclear what is behind this. despite the pfizer contract for 10 million doses, you would think the stock would be up. guy: it is off its lows. there is some positive news. abigail, thank you bring much. coming up, let's talk about what the next when he for hours will look like. in a...
146
146
Jan 26, 2022
01/22
by
LINKTV
tv
eye 146
favorite 0
quote 0
meanwhile, in australia, health authorities approved the novavax vaccine for adults amid an ongoing surge. it's expected to roll out next month. new zealand has imposed its toughest restrictions yet after at least nine omicron cases were detected. in south korea, covid cases hit a new daily record of 13,000. china lifted its lockdown in the city of xi'an this week, where 13 million residents had been ordered to stay at home since december 22 as part of the country's zero-covid strategy. beijing continues to report new daily cases, though overall numbers remain low, as the winter olympics are set to kick off at the end of next week. officials have sealed off beijing neighborhoods near the games and have conducted mass testing of some 2 million people in the run-up to the event. dozens of people associated with the olympics have tested positive so far. in the netherlands, officials are loosening restrictions despite record cases, allowing bars, restaurants and theaters to reopen starting today. ireland also recently removed most of its covid curbs, including curfews on hospitality venues an
meanwhile, in australia, health authorities approved the novavax vaccine for adults amid an ongoing surge. it's expected to roll out next month. new zealand has imposed its toughest restrictions yet after at least nine omicron cases were detected. in south korea, covid cases hit a new daily record of 13,000. china lifted its lockdown in the city of xi'an this week, where 13 million residents had been ordered to stay at home since december 22 as part of the country's zero-covid strategy. beijing...
105
105
Jan 27, 2022
01/22
by
CNBC
tv
eye 105
favorite 0
quote 0
the biggest laggards novavax and moderna.rge in early 2021 on vaccine adoption you got new strains now which means new vaccines, work costing going up and a boon for manufacturers are hitting judicial roadblocks and lockdowns are easing kelly? >> already a tough year and tougher now. thank you. >>> up next, the device that warned athletes to the ceo they had covid before they felt sick. we'll talk to the ceo next here's show and tell shares of intel down 6% despite better than expectedresults. missed on the lower forecast the ceo told tech check earlier intel is playing the long game >> on the foundry business, hey, that is long play. you know customers, takes a couple years to move designs into a newfound ri and an expansion for intel and as i said on the call yesterday we are a bit ahead of the schedule i set for that. the momentum from e stthcuomer and the industry ♪ ♪ wow, we're crunching tons of polygons here! what's going on? where's regina? hi, i'm ladonna. i invest in invesco qqq, a fund that gives me access to the na
the biggest laggards novavax and moderna.rge in early 2021 on vaccine adoption you got new strains now which means new vaccines, work costing going up and a boon for manufacturers are hitting judicial roadblocks and lockdowns are easing kelly? >> already a tough year and tougher now. thank you. >>> up next, the device that warned athletes to the ceo they had covid before they felt sick. we'll talk to the ceo next here's show and tell shares of intel down 6% despite better than...
107
107
Jan 14, 2022
01/22
by
LINKTV
tv
eye 107
favorite 0
quote 0
the shot, made by novavax, is the fifth to be approved in the country. in paris you can now go outside without wearing a mask. this coming after an order from the government that masks be worn on the streets of paris. our correspondent has the detail. >> mandatory masking in paris deemed unjustified by a french court. parisians have had to mask up in the streets, following a decision by city officials to curb the rapid spread of the omicron variant. with the mandate overturned on friday, residents are divided over freeing their faces. >> [speaking french] >> [speaking french] >> the greater paris region has been hotspot for omicron spread, but this suggests it will have less of an impact on hospitals than anticipated. it is not clear how much of a difference outdoor masking has made. >> [speaking french] >> france has faced an explosion of covid cases. average infections have reached 300,000 per day. in paris, masks remained mandatory on public transportation and in indoor public spaces, including shops and crowded outdoor areas, such as markets. >> for
the shot, made by novavax, is the fifth to be approved in the country. in paris you can now go outside without wearing a mask. this coming after an order from the government that masks be worn on the streets of paris. our correspondent has the detail. >> mandatory masking in paris deemed unjustified by a french court. parisians have had to mask up in the streets, following a decision by city officials to curb the rapid spread of the omicron variant. with the mandate overturned on friday,...
69
69
Jan 1, 2022
01/22
by
CSPAN2
tv
eye 69
favorite 0
quote 0
virus is going to be with us for a while as vaccines come into play this ilpast few weeks they have a novavax vaccine which is a. high-protein with a powerful adjuvant in roughly 90% effective including those who are over 65 years of age,ou we'l see how that plays out i think what's going to happen over time yet more and more experience with this vaccine now that a billion people have been vaccinated, more than 7 billion people i i think you will find that there will be differences in safety profiles, there will be differences to protect against as more variants arise. we will learn as we go we will see how that plays out as an international level. >> i'm sure we will learn a lot more. >> we talk about the vaccines not work. as you already mentioned we got so lucky there was no reason to believe that we would have such safe effective vaccines. when we talk about vaccines and media in the general population, we talk about how well vaccines work. i don't measure whether vaccines work, we measure efficacy, safety, effectiveness, doesn't prevent infection, does it prevent hospitalization, any dis
virus is going to be with us for a while as vaccines come into play this ilpast few weeks they have a novavax vaccine which is a. high-protein with a powerful adjuvant in roughly 90% effective including those who are over 65 years of age,ou we'l see how that plays out i think what's going to happen over time yet more and more experience with this vaccine now that a billion people have been vaccinated, more than 7 billion people i i think you will find that there will be differences in safety...
62
62
Jan 2, 2022
01/22
by
KRON
tv
eye 62
favorite 0
quote 0
novavax submitted its final data to the fda on friday. the vaccine is derived from the spike protein pulled from the very first strain of the novel covid. coronavirus, a late stage trial showed it was more than 90% effective against a variety of covid variants, including delta. but the maryland-based company is still working to develop a vaccine specifically for omicron. former president donald trump is now weighing in on a recent congressional primary. the former president is endorsing freshman representative mary miller who has been a staunch supporter of his. she's running against fellow incumbent representative rodney davis miller seat in congress was cut because of new redistricting maps, members of congress do not have to live in the district that they represent. atnt along with rising are scheduled to fire up their 5 g services. this coming tuesday. but the u.s. transportation secretary and the faa say they want the start of delayed for up to 2 weeks near airports, transportation chief pete buttigieg and steve dickson of the faa ar
novavax submitted its final data to the fda on friday. the vaccine is derived from the spike protein pulled from the very first strain of the novel covid. coronavirus, a late stage trial showed it was more than 90% effective against a variety of covid variants, including delta. but the maryland-based company is still working to develop a vaccine specifically for omicron. former president donald trump is now weighing in on a recent congressional primary. the former president is endorsing...
184
184
Jan 10, 2022
01/22
by
CNBC
tv
eye 184
favorite 0
quote 0
projecting $18.5 billion and seeing the stock up the most of the vaccine makers and biontech and novavaxg higher and pfizer which is moving up there. pfizer ceo also joined us this morning, gave us a taste of what he is looking at in terms of what the future holds for covid. >> i believe we'll continue to be present because it's spread everywhere and because boert natural infection and vaccine produced not durable immune protection but we can have it perfectly controlled we will have perfectly normal lives. an injection maybe once a year in case we are sick we will have make it like flu-like rather than life threatening disease. >> merck and gilead with anti-viral news in covid gilead starting a trial of a pill both stocks are moving up. guys >> thank you 8 of the top 9 stocks in the s&p health care related. >>> goldman with a note predicting the fed to raise rates four times this year and joining us to break down the call and hirere's a check on bonds. 10-year yield got above 1.8% it backed off from there see 1.773 on the 10-year "closing bell" will be right back your record label is ta
projecting $18.5 billion and seeing the stock up the most of the vaccine makers and biontech and novavaxg higher and pfizer which is moving up there. pfizer ceo also joined us this morning, gave us a taste of what he is looking at in terms of what the future holds for covid. >> i believe we'll continue to be present because it's spread everywhere and because boert natural infection and vaccine produced not durable immune protection but we can have it perfectly controlled we will have...
75
75
Jan 7, 2022
01/22
by
CNBC
tv
eye 75
favorite 0
quote 0
. >>> don't forget to tune in to cnbc's coverage of the press conference on monday the ceo of novavaxhe major averages all lower, the selling of the nasdaq, in particular, is accelerating this morning. we're at session lows on track for the worst week since february of 2021 "squawk on the street" is back i' oh. their award-winning content is tailored to fit your investing goals and interests. and it learns with you, so as you become smarter, so do its recommendations. so it's like my streaming service. well except now you're binge learning. see how you can become a smarter investor with a personalized education from td ameritrade. visit tdameritrade.com/learn ♪ your shipping manager left to “find themself.” leaving you lost. you need to hire. i need indeed. indeed you do. indeed instant match instantly delivers quality candidates matching your job description. visit indeed.com/hire ♪ ♪ wow, we're crunching tons of polygons here! what's going on? where's regina? hi, i'm ladonna. i invest in invesco qqq, a fund that gives me access to the nasdaq-100 innovations, like real time cgi. okay
. >>> don't forget to tune in to cnbc's coverage of the press conference on monday the ceo of novavaxhe major averages all lower, the selling of the nasdaq, in particular, is accelerating this morning. we're at session lows on track for the worst week since february of 2021 "squawk on the street" is back i' oh. their award-winning content is tailored to fit your investing goals and interests. and it learns with you, so as you become smarter, so do its recommendations. so it's...
105
105
Jan 31, 2022
01/22
by
CNBC
tv
eye 105
favorite 0
quote 0
novavax has requested the fda give emergency use authorization to its covid vaccine it's available forn more than 170 countries but in the u.s., it would provide an alternative to vaccines developed with mrna like those from pfizer and moderna. you're now up to date. sara, back to you. >> rahel, thank you. >>> up next, regulating the metaverse. tusk ventures bradley tusk outlines key questions that need to be addressed and what the government should be doing right now. >>> later, mizuho naming tesla one of its top picks for the year an analyst behind the outline, the tailwinds that could lead to big gains. it's jumping 10%, still down 11% or so for the year we'll be right back. well, would you look at that? jerry, you gotta see this. seen it. trust me, after 15 walks... gets a little old. i really should be retired by now. wish i'd invested when i had the chance... to the moon! ugh. unbelievable. at vanguard, you're more than just an investor, you're an owner with access to financial advice, tools and a personalized plan that helps you build a future for those you love. vanguard. becom
novavax has requested the fda give emergency use authorization to its covid vaccine it's available forn more than 170 countries but in the u.s., it would provide an alternative to vaccines developed with mrna like those from pfizer and moderna. you're now up to date. sara, back to you. >> rahel, thank you. >>> up next, regulating the metaverse. tusk ventures bradley tusk outlines key questions that need to be addressed and what the government should be doing right now....
63
63
Jan 2, 2022
01/22
by
KRON
tv
eye 63
favorite 0
quote 0
vaccine could get authorization for emergency use here in the united states as early as next month's novavax submitted its final data to the fda on friday. the vaccines derived from the spike protein pulled from the very first rain of the novel coronavirus a late stage trial showed it was more than 90% effective against a variety of covid variants, including delta. but the maryland based company is still working to develop a vaccine specifically 4th the omicron variant dave. okay. with the frost. that means clear skies were happening overnight and they continue through today with the generally speaking, mostly sunny skies will be into the mid-fifties. a look at that. 4 zone forecast in the extended rain coming and going. the kron 00:00am morning news. >> continues. chase first banking. a debit card for kids, and a set of tools to help them learn good money habits. by creating allowances and assigning chores, they can practice earning every day. with a debit card just for them, they'll learn smart spending firsthand, while you monitor and set account alerts. and using their own chase mobile a
vaccine could get authorization for emergency use here in the united states as early as next month's novavax submitted its final data to the fda on friday. the vaccines derived from the spike protein pulled from the very first rain of the novel coronavirus a late stage trial showed it was more than 90% effective against a variety of covid variants, including delta. but the maryland based company is still working to develop a vaccine specifically 4th the omicron variant dave. okay. with the...
94
94
Jan 31, 2022
01/22
by
FBC
tv
eye 94
favorite 0
quote 0
lauren is with us, novavax, saw it going straight up on friday. lauren: 14% on friday. 10% today.untries. not the u.s. yet, not israel. israil agreed to buy the vaccines even though not approved there they have bout five million doses. they have the ability to five million more. that is win shore fair shoulders. stuart: smile direct club a lot in the covid era. up four 1/2. 252 per share. lauren: it is still such a cheap stock. they have gotten crushed since their 2019 ipo but morgan stanley basically says, enough is enough. they have reset their sales expectations. they do see a profit by 2025. sounds like a big gain, 4 1/2% is nothing on a 2.50 stock. stuart: tell us about the elevator people, otis. up 2 1/2%. lauren: they grewe sales in new equipment and services in the last quarter. the full year outlook, that was below forecast but investors clearly seeing the positive today. stuart: okay. quite a few stocks, very much in the green today, like to see that. >>> new abc poll shows voters are giving president biden thumbs down on inflation. give us the rest of the numbers ashley
lauren is with us, novavax, saw it going straight up on friday. lauren: 14% on friday. 10% today.untries. not the u.s. yet, not israel. israil agreed to buy the vaccines even though not approved there they have bout five million doses. they have the ability to five million more. that is win shore fair shoulders. stuart: smile direct club a lot in the covid era. up four 1/2. 252 per share. lauren: it is still such a cheap stock. they have gotten crushed since their 2019 ipo but morgan stanley...